Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Back-To-Back FDA Holds, Solid Hopes To Regain Footing For Duchenne Candidate

Executive Summary

The US FDA wants more information on the first patient given SGT-001, who was hospitalized with a reduced platelet count after dosing. Solid says the patient is doing well and hopes to reply to the FDA's concerns within weeks.
Advertisement

Related Content

Finance Watch: Gossamer, Alector And Harpoon Launch First Biopharma IPOs Of 2019
Start-Up Quarterly Statistics: Financings Finally Rise In Q1, But Deals Stagnate
IPO Update: Seven In January As Big Returns, Solid's Slip-Up Contribute To Bubble Concerns

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC122923

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel